Gene/Protein Disease Symptom Drug Enzyme Compound
Pivot Concepts:   Target Concepts:
Query: UNIPROT:P46098 (5-HT3 receptor)
 2,290 document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)

The neuronal pathway that initiates nitric oxide-mediated descending relaxation in rat ileum was studied. The descending relaxation, which was suggested to be mediated by nitric oxide from our previous study, was selectively inhibited by 5-HT3 receptor antagonists. It was also inhibited by a nicotinic acetylcholine receptor antagonist. Exogenous 5-hydroxytryptamine (5-HT) and a selective 5-HT3 receptor agonist induced dose-dependent relaxation of ileal circular muscle. 5-HT-induced relaxation was selectively inhibited by 5-HT3 receptor antagonists. Nicotine also induced relaxation of the circular muscle, and its effect was inhibited by 5-HT3 receptor antagonists. 5-HT and nicotine increased the cyclic GMP content of the ileal tissue. Nitro-L-arginine inhibited the increases induced by both compounds in the cyclic GMP content, and a 5-HT3 receptor antagonist also inhibited that induced by nicotine. These results indicate that activation of a cholinergic neuron-5-HT neuron pathway initiates nitric oxide-mediated descending relaxation in rat ileum.
 ...
PMID:Neuronal pathway involved in nitric oxide-mediated descending relaxation in rat ileum. 811 25

N(G)-(Nitro-L-arginine (L-NOARG), an inhibitor of nitric oxide synthase, induces catalepsy in mice. The objective of the present work was to investigate if serotonergic drugs are able to modulate this effect. Results showed that the cataleptogenic effect of L-NOARG (40 mg/kg) in male albino-Swiss mice was enhanced by pre-treatment with (+)-N-tert-butyl-3-(4-[2-methoxyphenyl]piperazin-1-yl)-2-phenylpro panamide ((+)-WAY-100135, 5 or 10 mg/kg), a 5-HT1A-selective receptor antagonist, and by ketanserin (5 or 10 mg/kg), a 5-HT2A receptor and alpha1-adrenoceptor antagonist. Prazosin (3 or 5 mg/kg), an alpha1-adrenoceptor antagonist, and endo-N-(8-methyl-8-azabicyclo[3.2.1]oct-3yl)-2,3-dihydro-3,3-dimet hyl-indole-1-carboxamide HCl (BRL-46470A, 0.05 or 0.5 mg/kg), a 5-HT3 receptor antagonist, did not interfere with L-NOARG-induced catalepsy. Ritanserin (3 or 10 mg/kg), a 5-HT2A and 5-HT2C receptor antagonist, tended to enhance the effect of L-NOARG. These results confirm that interference with the formation of nitric oxide induces catalepsy in mice, and suggest that this effect is modulated by 5-HT1A and 5-HT2A receptors.
 ...
PMID:Serotonin modulation of catalepsy induced by N(G)-nitro-L-arginine in mice. 1049 70